Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:4
Dear Editor:
In the December 2005 issue of WOUNDS, Frye and Luterman published an article on hypertrophic scar formation and its relation to 2 different treatment regimes [Frye KE, Luterman A. Decreased incidence of hypertrophic burn scar formation with the use of collagenase, an enzymatic debriding agent. WOUNDS. 2005;17(12):332–336.].
The authors state that better cosmetic outcomes and fewer problems with hypertrophic scars may be attributed to the use of collagenase. - Issue:4
Staphylococcus aureus is an important pathogen in human infections and is implicated in a wide variety of infections, from mild skin infections to more serious and invasive infections, including septicemia, pneumonia, endocarditis, deep-seated abscesses, and toxinoses including food poisoning and toxic shock syndrome.1,2 The discovery of antimicrobial agents has been a critical element of the therapeutic armamentarium of modern medicine, but the treatment of infections caused by S aureus is still a challenge for clinicians.3,4 Numerous studies have in
- Issue:4
The risk of infection and amputation related to neuropathic ulcerations in the diabetic population drives the desire for timely and optimal healing in these patients.
- Issue:4
On December 26, 2004, a strong earthquake off the west coast of northern Sumatra triggered a devastating tsunami that hit 8 countries in south Asia, southeast Asia, and east Africa. The tsunami disaster caused more than 280,000 victims, and many of the survivors subsequently died from infection.
- Issue:4
Nitric oxide (NO), a gaseous free radical, is a critical mediator of normal tissue repair.1 Angiogenesis,2 granulation tissue formation,3 epidermal migration,4 and collagen deposition5 are all significant wound repair processes that are regulated by NO bioactivity. General somatic and wound NO bioactivity may be evaluated by measuring nitrate and nitrite (NOx, the stable oxidation products of NO) from plasma and urine and from wound fluid NOx, respectively.
- Issue:4
Kendall Introduces New Foam Dressings Kendall (Mansfield, Mass) introduces a new generation of dressings—CURITY™ AMD™ Packing Strips and COPA™ Ultra-Soft Foam Dressings. These dressings are the latest extension of the company’s family of dressings that deliver both clinical and financial benefits. The application of a broad-spectrum antimicrobial agent, polyhexamethylene biguanide (PHMB), makes the packing strips 7,000 times more effective than iodoform but with a lower cytotoxic profile. The packing strips are proven to be simple to use and p
- Issue:4
Healthpoint Acquires Topical Collagenase Business Healthpoint (Fort Worth, Tex) and BioSpecifics Technologies Corp. (Lynbrook, NY) announce the sale of BioSpecifics’ topical collagenase business. As part of the agreement, Healthpoint’s affiliate will assume ownership and operation of the BioSpecifics’ manufacturing facility in Curaçao and other assets owned by BioSpecifics’ affiliate, Advance Biofactures Corporation. The deal will involve $8 million in upfront cash to BioSpecifics and an additional payment for future services to be provided b
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
